Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Shandong Weigao Group Medical Polymer Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Shandong Weigao Group Medical Polymer Company Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

22 May 2016 Wright Reports 56 $75.00

Thomson Reuters Stock Report - Shandong Weigao Group Medical Polymer Co Ltd (1066-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

20 May 2016 Thomson Reuters Stock Report 11 $25.00

Thomson Reuters Stock Report - Shandong Weigao Group Medical Polymer Co Ltd (1066-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

15 May 2016 Thomson Reuters Stock Report 11 $25.00

Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review

Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review Summary Shandong ...

05 May 2016 GlobalData 43 $300.00

1066.HK - Event Transcript of Shandong Weigao Group Medical Polymer Co Ltd conference call, Mar. 22, 2016 / 8:00AM ET

Edited Event Transcript of 1066.HK conference call, Mar. 22, 2016 / 8:00AM ET Boston, Mar 22, 2016 (Thomson StreetEvent...

22 Mar 2016 Thomson Reuters StreetEvents 14 $75.00

Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review

Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review Summary Shandong ...

07 Mar 2016 GlobalData 43 $300.00

威高股份 (1066 HK) –– 业务前景渐见明朗

最新关注:威高股份2015年上半年收入RMB28.77亿,按年上升13.1%。三大业务分部耗材(如输液器、医用针制品、注射器、预充式注射器、血袋及创伤手术护理产品)、骨科及血液净化产品期内收入分别为RMB21.25亿、3.56亿和3.96亿,按年分别...

01 Feb 2016 SBI China Capital 6 $46.00

Shandong Weigao Group Medical Polymer Co: Upgraded to Above Average

19 Jan 2016 Sadif Analytics Prime 3 $10.00

Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review

Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review Summary Shandong ...

04 Dec 2015 GlobalData 43 $300.00